OBSOLETE: Multifocal muscular fibrosis-obstructed vessels syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:2033
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Multifocal muscular fibrosis-obstructed vessels syndrome is an extremely rare condition that has been described in medical literature under this name but is now considered an obsolete term in disease classification databases like Orphanet (code 2033). This condition was characterized by the development of abnormal fibrous (scar-like) tissue in multiple muscles throughout the body, along with blockage or narrowing of blood vessels. The fibrosis in the muscles could lead to stiffness, reduced movement, and pain, while the obstructed blood vessels could impair blood flow to various organs and tissues. Because this disease entry is now classified as obsolete, it is possible that the condition has been reclassified under a different name, merged with another recognized diagnosis, or better understood as part of a broader category of fibrosing or vascular disorders. Patients who were previously given this diagnosis should work with their medical team to determine whether a more current diagnostic label applies to their condition. Treatment for conditions involving muscle fibrosis and vascular obstruction is generally supportive and symptom-based. This may include physical therapy to maintain mobility, medications to manage pain and inflammation, and vascular interventions if blood vessel blockages are significant. Because so little is known about this specific syndrome, management is highly individualized and typically involves a multidisciplinary team of specialists.

Key symptoms:

Muscle stiffness or tightness in multiple areas of the bodyReduced range of motion in affected limbsMuscle pain or tendernessHardened or firm areas within musclesPoor blood circulation in arms or legsCold or discolored fingers or toesMuscle weaknessJoint contractures (joints that become fixed in one position)FatigueDifficulty with movement or walking

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for OBSOLETE: Multifocal muscular fibrosis-obstructed vessels syndrome.

View clinical trials →

No actively recruiting trials found for OBSOLETE: Multifocal muscular fibrosis-obstructed vessels syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the OBSOLETE: Multifocal muscular fibrosis-obstructed vessels syndrome community →

No specialists are currently listed for OBSOLETE: Multifocal muscular fibrosis-obstructed vessels syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to OBSOLETE: Multifocal muscular fibrosis-obstructed vessels syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open OBSOLETE: Multifocal muscular fibrosis-obstructed vessels syndromeForum →

No community posts yet. Be the first to share your experience with OBSOLETE: Multifocal muscular fibrosis-obstructed vessels syndrome.

Start the conversation →

Latest news about OBSOLETE: Multifocal muscular fibrosis-obstructed vessels syndrome

No recent news articles for OBSOLETE: Multifocal muscular fibrosis-obstructed vessels syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Is this diagnosis still considered accurate, or has it been reclassified under a different condition?,What tests should be done to monitor the progression of muscle fibrosis and blood vessel involvement?,Are there any medications that could slow down the fibrosis process?,What type of physical therapy would be most helpful for maintaining mobility?,Should I see a vascular specialist to evaluate my blood vessel health?,Are there any genetic tests that might help identify the underlying cause?,Are there any clinical trials or research studies I could participate in?

Common questions about OBSOLETE: Multifocal muscular fibrosis-obstructed vessels syndrome

What is OBSOLETE: Multifocal muscular fibrosis-obstructed vessels syndrome?

Multifocal muscular fibrosis-obstructed vessels syndrome is an extremely rare condition that has been described in medical literature under this name but is now considered an obsolete term in disease classification databases like Orphanet (code 2033). This condition was characterized by the development of abnormal fibrous (scar-like) tissue in multiple muscles throughout the body, along with blockage or narrowing of blood vessels. The fibrosis in the muscles could lead to stiffness, reduced movement, and pain, while the obstructed blood vessels could impair blood flow to various organs and tis